Vitamin Biomarkers Market Report 2026

Vitamin Biomarkers Market Overview

• Vitamin Biomarkers market size has reached to $4.02 billion in 2025 • Expected to grow to $7.18 billion in 2030 at a compound annual growth rate (CAGR) of 12.3% • Growth Driver: Surge In Prevalence Of Nutrition Deficiencies Driving Market Growth Due To Increased Need For Accurate Vitamin Status Assessment • Market Trend: Embedding At‑Home Lab‑Quality Vitamin D Testing for Precision Wellness • North America was the largest region in 2025.

What Is Covered Under Vitamin Biomarkers Market?

Vitamin biomarkers are measurable indicators in the body that reflect the status or levels of specific vitamins. They assess an individual's nutritional status and help diagnose deficiencies or excesses of particular vitamins. These biomarkers are often measured through blood, urine, or tissue samples and can provide insights into how well the body absorbs, metabolizes, and utilizes vitamins. The main component types of vitamin biomarkers are serum retinol (vitamin A), ascorbic acid (vitamin C), serum 25(OH)D (vitamin D), serum alpha-tocopherol (vitamin E), serum prothrombin (vitamin K), serum thiamine diphosphate (vitamin B1), serum glycolate (vitamin B2), serum niacin (vitamin B3), serum plasma PLP (vitamin B6), and others. Serum retinol, also known as vitamin A, is a biomarker that measures the concentration of retinol in the blood, essential for vision, immune function, and skin health, which also helps diagnose vitamin A deficiencies or excesses. The products include analyzers, test kits, reagents, and consumables utilizing types of testing methods such as enzyme-linked immunosorbent assays (ELISA), liquid chromatography with tandem mass spectrometry (LC MS MS), high-performance liquid chromatography (HPLC), and chemiluminescent immunoassays (CLIA) for types of end users, including hospitals, diagnostic laboratories, ambulatory diagnostic centers, and homecare settings.

What Is The Vitamin Biomarkers Market Growth Forecast?

The vitamin biomarkers market size is expected to see rapid growth in the next few years. It will grow to $7.18 billion in 2030 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to growth in preventive healthcare, expansion of personalized nutrition, increasing diagnostic automation, rise in home-based testing, growing elderly population. Major trends in the forecast period include rising demand for nutritional deficiency testing, increasing use of advanced diagnostic assays, growing focus on preventive healthcare diagnostics, expansion of laboratory-based vitamin testing, increased adoption of high-precision testing methods.

Global Vitamin Biomarkers Market Segmentation

1) By Biomarker Type: Serum Retinol (Vitamin A), Ascorbic Acid (Vitamin C), Serum 25(OH)D (Vitamin D), Serum Alpha-tocopherol (Vitamin E), Serum Prothrombin (Vitamin K), Serum Thiamine Diphosphate (Vitamin B1), Serum Glycolate (Vitamin B2), Serum Niacin (Vitamin B3), Serum Plasma PLP (Vitamin B6), Other Biomarker Types 2) By Product: Analyzers, Test Kits, Reagents And Consumables 3) By Testing Method: Enzyme Linked Immunosorbent Assay (ELISA), Liquid Chromatography With Tandem Mass Spectrometry (LC MS MS), High Performance Liquid Chromatography (HPLC), Chemiluminescent Immunoassay (CLIA) 4) By End User: Hospitals, Diagnostic Laboratories, Ambulatory Diagnostic Centers, Homecare Settings Subsegments: 1) By Serum Retinol (Vitamin A): Retinol Measurement Kits, Retinol Assay Reagents 2) By Ascorbic Acid (Vitamin C): Vitamin C Detection Kits, Ascorbic Acid Assay Reagents 3) By Serum 25(OH)D (Vitamin D): Vitamin D Testing Kits, 25-Hydroxyvitamin D Assay Reagents 4) By Serum Alpha-tocopherol (Vitamin E): Alpha-tocopherol Measurement Kits, Vitamin E Assay Reagents 5) By Serum Prothrombin (Vitamin K): Prothrombin Time Testing Kits, Vitamin K Assay Reagents 6) By Serum Thiamine Diphosphate (Vitamin B1): Thiamine Measurement Kits, Vitamin B1 Assay Reagents

What Is The Driver Of The Vitamin Biomarkers Market?

The increasing prevalence of nutrition deficiencies is expected to propel the growth of the vitamin biomarkers market going forward. Nutrition deficiencies refer to a lack of essential nutrients in the diet, leading to adverse health effects. Rising nutrition deficiencies are due to increased consumption of unbalanced diets and highly processed foods, which often lack essential vitamins and minerals necessary for proper health. Vitamin biomarkers are used to diagnose nutrition deficiencies by measuring specific vitamins in the blood to assess nutritional status and guide interventions. For instance, in January 2025, according to The Guardian, a UK-based news and media organization, there were 191,927 hospital admissions in 2023-24 due to iron deficiency, up 11 percent from 2022-23, and 2,630 admissions due to B vitamin deficiency other than folate, up 15 percent from the previous year. Therefore, the increasing prevalence of nutrition deficiencies will drive the growth of the vitamin biomarkers industry.

Key Players In The Global Vitamin Biomarkers Market

Major companies operating in the vitamin biomarkers market are Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Siemens Healthineers AG, Roche Diagnostics International Ltd., Agilent Technologies Inc, PerkinElmer Inc, bioMérieux SA, Beckman Coulter Inc, Shimadzu Corporation, QuidelOrtho Corporation, Sysmex Corporation, Waters Corporation, Bio-Rad Laboratories Inc, Tecan Group Ltd, Randox Laboratories Ltd, Ortho Clinical Diagnostics Inc, Molecular Devices LLC, Cambridge Isotope Laboratories Inc, Luminex Corporation, DiaSorin SpA, Analytik Jena AG, SeraCare Life Sciences Inc, Biopanda Reagents Ltd, SiPhox Inc

Global Vitamin Biomarkers Market Trends and Insights

Major players in the vitamin biomarker market are increasingly developing at-home, lab‑quality testing kits that enable users to monitor essential nutrients like vitamin D conveniently, accurately, and affordably. These innovations support preventive healthcare by democratizing access to nutrient-level data, allowing individuals and clinicians to make personalized interventions based on real-time biomarker insights. For instance, in February 2023, Hurdle, a US-based diagnostics platform under Chronomics Inc., launched a vitamin D test that uses a simple finger-prick sample to provide quantitative lab-quality results from home. The test delivers results, including explanations of vitamin D’s role in the body and potential causes of abnormal levels, within three days via a secure personal dashboard. This launch aligns with broader market trends: rising global awareness of vitamin D deficiency, growing demand for remote testing, and the integration of wellness diagnostics into telehealth and preventive care.

What Are Latest Mergers And Acquisitions In The Vitamin Biomarkers Market?

In December 2023, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., a China-based medical equipment manufacturing company, acquired a 75% stake in DiaSys Diagnostic Systems GmbH for an undisclosed amount. This acquisition will enhance Mindray's market presence in diagnostic solutions and expand its technological expertise. DiaSys Diagnostic Systems GmbH is a Germany-based company actively involved in researching and developing various biomarkers, including those related to vitamins.

Regional Insights

North America was the largest region in the vitamin biomarkers market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Vitamin Biomarkers Market?

The vitamin biomarkers market consists of revenues earned by entities by providing services such as vitamin level testing, diagnostic assessments, nutritional monitoring, and personalized health management to detect deficiencies or excesses of specific vitamins. The market value includes the value of related goods sold by the service provider or included within the service offering. The vitamin biomarkers market also includes sales of diagnostic assays, test kits, laboratory reagents, analytical instruments, and point-of-care devices used to measure and analyze vitamin levels in biological samples. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Vitamin Biomarkers Market Report 2026?

The vitamin biomarkers market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the vitamin biomarkers industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.